Market Value482,133,000
Total Holdings43
File Date2020-04-09
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
QQQ / Invesco QQQ Trust, Series 1 Put
ALNY / Alnylam Pharmaceuticals, Inc.
TCDA / Tricida Inc
MIST / Milestone Pharmaceuticals Inc.
DRNA / Dicerna Pharmaceuticals Inc
FIXX / Homology Medicines, Inc.
SRPT / Sarepta Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Put
EPZM / Epizyme Inc
KDMN / Kadmon Holdings Inc
FXF / Invesco CurrencyShares Swiss Franc Trust
GNCA / Genocea Biosciences Inc
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
BOLD / Boundless Bio, Inc.
ANAB / AnaptysBio, Inc.
/ Immunomedics, Inc.
/ Immunomedics, Inc. Call
US16706W1027 / Chiasma Inc
ZYME / Zymeworks Inc.
ODT / Odonate Therapeutics Inc
ONCE / Spark Therapeutics, Inc.
OBSV / ObsEva SA.
RARX / Ra Pharmaceuticals, Inc.
BPMC / Blueprint Medicines Corporation
US60877T1007 / Momenta Pharmaceuticals, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
GBT / Global Blood Therapeutics Inc.
ARQL / ArQule, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
ACAD / ACADIA Pharmaceuticals Inc.
MRTX / Mirati Therapeutics, Inc.
FGEN / FibroGen, Inc.
CBIO / Crescent Biopharma, Inc.
TVTX / Travere Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.
CHRS / Coherus Oncology, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
ALLK / Allakos Inc.
SLDB / Solid Biosciences Inc.
SAGE / Sage Therapeutics, Inc.
PFE / Pfizer Inc. Put
IOVA / Iovance Biotherapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
VRAY / ViewRay Inc.
BHVN / Biohaven Ltd. Call
BHVN / Biohaven Ltd.
PTGX / Protagonist Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
QURE / uniQure N.V.
RCKT / Rocket Pharmaceuticals, Inc.
CBAY / CymaBay Therapeutics, Inc.
ARVN / Arvinas, Inc.
AXSM / Axsome Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put